Modulation of the discriminative stimulus properties of cocaine: Comparison of the effects of fluoxetine with 5-HT(1A) and 5-HT(1B) receptor agonists

Neuropharmacology

Volumn 36, Issue 3, 1997, Pages 373-381

  Callahan, P M ^a   Cunningham, K A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

5 HT reuptake inhibition; 5 HT(1A) receptor; 5 HT(1B) receptor; cocaine; dopamine (DA); drug discrimination; serotonin (5 HT)

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; BUSPIRONE; COCAINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUOXETINE; GEPIRONE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG POTENTIATION; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; BUSPIRONE; COCAINE; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS;

EID: 0030961683     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00010-5     Document Type: Article

References (47)

1. Auerbach S.B., Rutter J.J., Juliano P.J. Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis. Neuropharmacology. 30:1991;307-311.
2. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
3. Benloucif S., Keegan M.J., Galloway M.P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
4. 2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology. 103:1991;50-55.
5. 2 receptor function in rats. J. Pharmacol. Exp. Ther. 266:1993;585-592.
6. 2C receptors. J. Pharmacol. Exp. Ther. 274:1995;1414-1424.
7. Callahan P.M. and Cunningham K.A. (1995b) Analysis of the effects of diverse antidepressants on the discriminative stimulus effects of cocaine. In: Problems of Drug Dependence, 1994 (Harris L., Ed.), p. 388. National Institute on Drug Abuse Research Monograph No. 153. U.S. Government Printing Office, Washington, DC.
8. 1 receptors in the nucleus accunmbens. Psychopharmacology. 115:1994;110-114.
9. Callahan P.M., De La Garza R. II, Cunningham K.A. Mediation of the discriminative stimulus properties of cocaine by dopamine mesocorticolimbic systems. Pharmacol. Biochem. Behav. 57:1997;1-8.
10. Carli M., Invernizzi R., Cervo L., Samanin R. Neurochemical and behavioural studies with RU-24969 in the rat. Psychopharmacology. 94:1988;359-364.
11. 3H-paroxetine binding sites in the rat brain. J. Pharmacol. Toxicol. Meth. 27:1992;209-216.
12. Colpaert F.C., Niemegeers J.E., Janssen A.J. Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol. Biochem. Behav. 10:1979;535-546.
13. Cunningham K.A., Callahan P.M. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in rats. Psychopharmacology. 104:1991;177-180.
14. Dworkin S.I. and Smith J.E. (1988) Neurobehavioral pharmacology of cocaine. In: Mechanisms of Cocaine Abuse and Toxicology (Clouet D., Ashgar K. and Brown R., Eds), pp. 185-197. National Institute on Drug Abuse Research Monograph No. 88. U.S. Government Printing Office, Washington, DC.
15. Extance K., Goudie A.J. Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology. 73:1981;363-371.
16. Fuller R.W., Wong D.T. Serotonin reuptake blockers in vitro and in vivo. J. Clin. Psychopharmacol. 7:1987;36-43.
17. Gold L.H., Balster R.L. Effects of buspirone and gepirone on IV cocaine self- administration in rhesus monkeys. Psychopharmacology. 108:1992;289-294.
18. Goudie A.J., Reid D. Qualitative discrimination between cocaine and amphetamine in rats. Eur. J. Pharmacol. 151:1988;471-474.
19. 1B receptor mediated events. Soc. Neurosci. Abstr. 19:1993;1380.
20. 1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur. J. Pharmacol. 209:1991;249-252.
21. 1 recognition sites. J. Recept. Res. 8:1988;59-81.
22. Hyttel J. Citalopram: pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 6:1982;277-295.
23. Johanson C.E., Barrett J.E. The discriminative stimulus effects of cocaine in pigeons. J. Pharmacol. Exper. Ther. 267:1993;1-8.
24. Jordan S., Kramer G.L., Zukas P.K., Moeller M., Petty F. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine and fluvoxamine. Synapse. 18:1994;294-297.
25. Kamien J.B., Woolverton W.L. Buspirone blocks the discriminative stimulus effects of apomorphine in monkeys. Pharmacol. Biochem. Behav. 35:1990;118-120.
26. Keppel G. (1973) Design and Analysis: A Researcher's Handbook. Prentice-Hall, Englewood Cliffs, NJ.
27. Louilot A., LeMoal M., Simon H. A study of the effects of buspirone, BMY 13805 and 1-PP on dopaminergic metabolism in the nucleus accumbens using in vivo voltammetry in freely moving rats. Life Sci. 39:1986;685-692.
28. McKenna M.L., Ho B.T. The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology. 19:1980;297-303.
29. McMillen B.A., Mattiace L.A. Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug. J. Neural Transm. 57:1983;255-265.
30. 1A agonists. Behav. Pharmacol. 5:1994;591-598.
31. 3 antagonists do not alter the discriminative stimulus properties of cocaine. Psychopharmacology. 104:1991;475-478.
32. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors Brain Res. 346:1985;205-239.
33. Peltier R.L., Emmett-Oglesby M.W., Thomas W.H., Schenk S. Failure of ritanserin to block the discriminative stimulus or reinforcing effects of cocaine. Pharmacol. Biochem. Behav. 48:1994;473-478.
34. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 271:1994;83-90.
35. Richelson E., Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selective block norepinephrine uptake. Eur. J. Pharmacol. 104:1984;277-286.
36. Rijnders H.J., Slangen J.L. The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity. Psychopharmacology. 111:1993;55-61.
37. 1B receptor ligands exist? Naunyn-Schmiedberg's Arch. Pharmacol. 339:1989;675-683.
38. 1D receptors mediating inhibition of adenylate cyclase activity: pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists. Naunyn-Schmiedberg's Arch. Pharmacol. 340:1989;285-292.
39. Spealman R.D. Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology. 112:1993;93-99.
40. Spealman R.D., Bergman J., Madras B.K., Melia K.F. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;945-953.
41. Tallarida R.J. and Murray R.B. (1987) Manual of Pharmacological Calculations with Computer Programs. Springer-Verlag, New York.
42. 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology. 119:1995;15-19.
43. Terry P., Witkin J.M., Katz J.L. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J. Pharmacol. Exp. Ther. 270:1994;1041-1048.
44. 1 receptor agonist, RU 24969, in the rat. Neuropharmacology. 8:1986;877-886.
45. Van Wijngaarden I., Tulp M.Th.M., Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. Mol. Pharmacol. 188:1990;301-312.
46. Wolf W.A., Kuhn D.M. The 5-HT transporter is an additional site of action for the 5-HT agonists RU 24969 and TFMPP. Neurochem. Int. 19:1991;39-44.
47. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:1995;411-441.